TOP OF THE NEWS
Growth at Meridian
Myriad to split pharma, molecular diagnostics
BUSINESS NEWS
Invitrogen, Applied Biosystems near merger
LabCorp discontinues OvaSure testing
DNA Diagnostics Center acquired
LabCorp to help launch Abu Dhabi lab
SCIENCE/TECHNOLOGY
Osmetech in trials for new warfarin test
Ikonisys gets FDA OK
Panel looks to future of genetic testing
Down syndrome test enters study
Blood test could predict heart attack
Genetic links to esophageal cancer
Comparing oral fluid and urine drug tests
New tumor database
INSIDE DIAGNOSTICS INDUSTRY
OncotypeDX found to influence treatment decisions
REGULATORY NEWS
Medicare physician fees to rise
CLIAC guidance to tackle molecular testing
CMS finalizes anti-markup rules
FINANCIAL NEWS
IVD stocks down 14%
G-2 INSIDER
A blood test to predict obesity?

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

December 2008 - Table of Contents

DTTR December 2008 (full PDF issue)

Meridian Sees Double-Digit Growth in Diagnostics

Myriad Genetics Will Split Molecular Diagnostics, Pharma

Osmetech Begins Trials for Extended Warfarin Sensitivity Test

Invitrogen, Applied Biosystems Progress Toward Merger

Ikonisys Gets FDA Clearance for HER-2 Breast Cancer Test

ACLA Panel Sees Future of Genetic Testing in Multiplex, Microrray Analysis

LabCorp Discontinues OvaSure Testing After FDA Warning

Medicare Physician Fees Will Rise in 2009

Inside the Diagnostics Industry: As Rising Costs Threaten Future of Cancer Care, OncotypeDX Found to Influence Treatment Decisions

Sequenom’s Down Syndrome Test Enters Study

Protein-Based Blood Test Could Predict Impending Heart Attack

Risk of Esophageal Cancer Tied to Gene Variants

Study Finds Oral Fluid Drug Test Results Comparable to Urine Testing

Tumor Database to Combine Microscopy, Microarray Information

New CLIAC Guidance Will Tackle Molecular Testing

Paternity Testing Leader DNA Diagnostics Center Acquired by MTS Health Investors

LabCorp to Help Launch Reference Lab in Abu Dhabi

CMS Finalizes Anti-Markup Rules for Diagnostic Testing

IVD Stocks Fall 14%; Affymetrix Plummets 45%

A Blood Test to Predict Obesity?